0001140361-23-002784.txt : 20230125 0001140361-23-002784.hdr.sgml : 20230125 20230125210038 ACCESSION NUMBER: 0001140361-23-002784 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230123 FILED AS OF DATE: 20230125 DATE AS OF CHANGE: 20230125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lefebvre Eric CENTRAL INDEX KEY: 0001614741 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39303 FILM NUMBER: 23553746 MAIL ADDRESS: STREET 1: C/O TOBIRA THERAPEUTICS, INC. STREET 2: 701 GATEWAY BOULEVARD, #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLIANT THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001746473 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474272481 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-481-6770 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4.xml X0306 4 2023-01-23 0001746473 PLIANT THERAPEUTICS, INC. PLRX 0001614741 Lefebvre Eric C/O PLIANT THERAPEUTICS, INC. 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 true Chief Medical Officer Common Stock 2023-01-23 4 S 0 67500 34.4834 D 76926 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. /s/ Mike Ouimette, attorney-in-fact 2023-01-25